Home The Word Brain My Amedeo FAQ Privacy About   


Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

Abstract • About • The 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF


  Obstructive Lung Diseases

  Free Subscription


Articles published in Respir Med

Retrieve available abstracts of 307 articles:
HTML format



Single Articles


    November 2025
  1. ZHAO L, Chen G, Huang C, Kong W, et al
    Machine learning for prediction of eosinophilic asthma using clinical indicators as an alternative to induced sputum.
    Respir Med. 2025 Nov 19:108528. doi: 10.1016/j.rmed.2025.108528.
    PubMed     Abstract available


  2. CHEN F, Ye J, Zhang L, Lin BQ, et al
    Associations of serum cotinine with asthma risk in US children: a mediation analysis of body mass index.
    Respir Med. 2025 Nov 12:108502. doi: 10.1016/j.rmed.2025.108502.
    PubMed     Abstract available


  3. BARRY LE, Habib M, Heaney LG, Nianogo RA, et al
    Socioeconomic Disparities in Inpatient Outcomes Among US Pediatric Asthma Hospitalizations.
    Respir Med. 2025 Nov 11:108501. doi: 10.1016/j.rmed.2025.108501.
    PubMed     Abstract available


  4. CHEN L, Chen H, Chen Z, Zhang K, et al
    Visceral obesity, partly mediated by a reduction in HDL-C, increases the risk of asthma: Insights from NHANES and Mendelian randomization studies.
    Respir Med. 2025;249:108482.
    PubMed     Abstract available


  5. BERTHON BS, Williams LM, McLoughlin RF, Nichol KS, et al
    Pilot investigation of an oligosaccharide blend in adults with asthma - a double-blind, randomised, placebo-controlled, 4-arm crossover trial.
    Respir Med. 2025 Nov 3:108474. doi: 10.1016/j.rmed.2025.108474.
    PubMed     Abstract available


  6. ZHANG S, Shen K, Sun B, Liu B, et al
    Associations of the prevalence of chronic respiratory diseases and mortality with blood furan levels: a population-based study.
    Respir Med. 2025;248:108422.
    PubMed     Abstract available


  7. HANSEN FR, Pedersen DC, Madsen F, Backman H, et al
    Childhood body size and risk of chronic obstructive pulmonary disease in adulthood: a prospective cohort study.
    Respir Med. 2025;248:108416.
    PubMed     Abstract available


  8. HARRISON SL, Loughran KJ, Suri S, Franklin A, et al
    The continuous daily work of living with chronic obstructive pulmonary disease: An ethnographic study.
    Respir Med. 2025;248:108405.
    PubMed     Abstract available


  9. ZHANG X, Xue J, Chang Y, Zhang R, et al
    Non-pharmacological interventions for fatigue in patients with chronic obstructive pulmonary disease: a systematic review and network meta-analysis.
    Respir Med. 2025;248:108409.
    PubMed     Abstract available


  10. MATERA MG, Page C, Cazzola M
    Sarcopenia as a treatable trait in COPD: From mechanisms to management.
    Respir Med. 2025;248:108401.
    PubMed     Abstract available


  11. BAKAKOS A, Sotiropoulou Z, Anagnostopoulos N, Vontetsianos A, et al
    Anti-inflammatory agents for the management of COPD - Quo Vadis?
    Respir Med. 2025;248:108396.
    PubMed     Abstract available


  12. CHOI JY, Yoon HK, Kim Y, Jang JG, et al
    Comparison of chronic bronchitis definitions in COPD for predicting 10-year all-cause mortality.
    Respir Med. 2025;248:108389.
    PubMed     Abstract available


  13. WANG H, Fan M, Wu J, Liu H, et al
    Development of a questionnaire on supportive care needs of patients with COPD combined with respiratory failure on noninvasive ventilators and evaluating its reliability and validity.
    Respir Med. 2025;248:108384.
    PubMed     Abstract available


  14. KARAKURT G, Demireller M, Ucgun H, Guven O, et al
    EzPAP therapy versus non-invasive ventilation for hypercapnic chronic obstructive pulmonary disease exacerbation: a randomized clinical trial.
    Respir Med. 2025;248:108383.
    PubMed     Abstract available


  15. ALVAREZ-MARTINEZ CJ, Hernandez M, Velez J, Sanchez-Covisa J, et al
    Clinical and economic impact of concomitant heart failure in patients with exacerbated COPD.
    Respir Med. 2025;248:108381.
    PubMed     Abstract available


  16. WU SC, Wu CY, Chien JY, Dong YH, et al
    Predicting response to inhaled corticosteroid maintenance therapy in patients with chronic obstructive pulmonary disease using machine learning models.
    Respir Med. 2025;248:108378.
    PubMed     Abstract available


  17. TSILIGIANNI I, Papageorgakopoulou S, Bouloukaki I
    Adherence to the Chronic Obstructive Pulmonary Disease guidelines in primary care: The Greek COPD COCARE study.
    Respir Med. 2025;248:108345.
    PubMed     Abstract available


  18. NIELSEN LB, Olsson M, Weinreich UM, Ekstrom M, et al
    Associations between chronic airflow limitation, respiratory symptoms, and quality of life across alcohol use categories: a population based study.
    Respir Med. 2025;248:108350.
    PubMed     Abstract available


  19. SUTER P, Greig R, Chan R, Lipworth B, et al
    Efficacy of dupilumab and mepolizumab in eosinophilic COPD: insights from phase 3 trials.
    Respir Med. 2025;248:108343.
    PubMed     Abstract available


  20. BHUTANI M, Mullerova H, Patel D, Barjaktarevic I, et al
    Disease burden and health-related outcomes of patients discharged from hospital following a COPD exacerbation in the United States.
    Respir Med. 2025;248:108337.
    PubMed     Abstract available


  21. CAZZOLA M, Hanania NA, Rogliani P
    Comorbidities as treatable traits of chronic airway diseases.
    Respir Med. 2025;248:108333.
    PubMed     Abstract available


  22. MOUROUVIN-CHEVOLOT E, Laurent L, Claude F, Westeel V, et al
    Distinctive computed tomography features of chronic obstructive pulmonary disease among dairy farmers and smokers.
    Respir Med. 2025;248:108319.
    PubMed     Abstract available


  23. SEPULVEDA-LOYOLA W, Tang C, Alvarez-Bustos A, Cuyul-Vasquez I, et al
    Exploring pulmonary rehabilitation programs implemented and conducted in Latin America for people with chronic respiratory conditions: A scoping review.
    Respir Med. 2025;248:108310.
    PubMed     Abstract available


  24. SANCHEZ FM, Bommatty MS, Haro MQ, Ruiz FO, et al
    Telemonitoring in patients with COPD: A prospective study with results from the AIRE project.
    Respir Med. 2025;248:108307.
    PubMed     Abstract available


  25. HE H, Qiu L, Yang H
    Age-specific profiles and ICU predictors in pediatric plastic bronchitis: A multicenter Chinese cohort study, 2014-2025.
    Respir Med. 2025;249:108473.
    PubMed     Abstract available


  26. GUPTA N, Mohan S, Cattamanchi A, Prasad B, et al
    Effect of eosinophilia on duration of hospital stay in patients admitted with acute exacerbation of chronic obstructive pulmonary disease.
    Respir Med. 2025;249:108467.
    PubMed     Abstract available


  27. YE RH, Wang Z, Ren Z, Mao YJ, et al
    Integrative therapy for lower limb venous thrombosis in patients with COPD: a trial of Rhodiola rosea polyglucoside and pulmonary rehabilitation as a synergistic combination.
    Respir Med. 2025;249:108466.
    PubMed     Abstract available


  28. YE W, Lu W, Yu H, Jia W, et al
    Global burden of young chronic obstructive pulmonary disease in 204 countries and territories from 1990 to 2021: analyses from the global burden of disease study 2021.
    Respir Med. 2025;249:108447.
    PubMed     Abstract available


  29. RANTALA HA, Leivo-Korpela S, Beerling C, Helminen M, et al
    Experienced benefits and side effects affect adherence with long-term noninvasive ventilation.
    Respir Med. 2025;249:108427.
    PubMed     Abstract available


  30. VENKATAPEN D, Caty G, Froidure A, Aboubakar Nana F, et al
    Effect of fan therapy on dyspnea in patients with chronic respiratory diseases during exercise: A randomized controlled trial.
    Respir Med. 2025;249:108426.
    PubMed     Abstract available


  31. AGUSTI A, Gibson P, Cazzola M
    Treatable Traits. Why, What, How?
    Respir Med. 2025;249:108421.
    PubMed     Abstract available


  32. VITACCA M, Riboni G, Paneroni M, Tibollo V, et al
    Timing of cardiovascular events in people with COPD with and without chronic respiratory failure.
    Respir Med. 2025;249:108429.
    PubMed     Abstract available


    October 2025
  33. KOWALCZYK ET, Medubi KM, Meyer MJ, Toriola MA, et al
    Development of novel pegylated imidazobenzodiazepines as inhaled asthma drug candidates.
    Respir Med. 2025 Oct 22:108449. doi: 10.1016/j.rmed.2025.108449.
    PubMed     Abstract available


  34. MACKLE R, Crespo-Gonzalez C, Gray M, Chan M, et al
    Implementing enhanced paediatric asthma care in rural Australia: Qualitative insights from healthcare professionals.
    Respir Med. 2025;249:108444.
    PubMed     Abstract available


  35. DA SILVA LIMA D, Rechenmacher C, Bernardi J, Velleda de Morais R, et al
    SMAD3 gene methylation profile and asthma in childhood: A longitudinal approach.
    Respir Med. 2025;249:108424.
    PubMed     Abstract available


  36. SUTER P, Greig R, Kuo CR, Chan R, et al
    Comparison of oscillometry ratios between IOS and AOS in patients with asthma and COPD.
    Respir Med. 2025 Oct 7:108402. doi: 10.1016/j.rmed.2025.108402.
    PubMed     Abstract available


  37. ARARAT E, Rastogi D, Martin BC
    Metformin use is associated with reduced systemic steroid courses among pediatric asthma patients with diabetes or elevated blood glucose levels.
    Respir Med. 2025 Oct 6:108403. doi: 10.1016/j.rmed.2025.108403.
    PubMed     Abstract available


  38. MURAOKA H, Tsuburai T, Komase Y, Tanaka S, et al
    Association between 6-min walk test and initiation of home oxygen therapy within 3 years in chronic obstructive pulmonary disease managed by primary care physicians.
    Respir Med. 2025;247:108317.
    PubMed     Abstract available


  39. DETTORAKI M, Vandorou KT, Tsoukalas D, Basagianni E, et al
    Ocular manifestations in COPD patients. An underrecognized comorbidity.
    Respir Med. 2025;247:108313.
    PubMed     Abstract available


  40. CAI S, Huang Q, Huang M, Wang J, et al
    Association of aspirin use with mortality in critically ill patients with chronic obstructive pulmonary disease: A retrospective propensity score-matched cohort study.
    Respir Med. 2025;247:108300.
    PubMed     Abstract available


  41. CAZZOLA M, Maniscalco M, Patella V, Calzetta L, et al
    Comparing major COPD triple therapy trials using a structured multi-criteria decision analysis: A deep dive into patient populations and outcomes.
    Respir Med. 2025;247:108292.
    PubMed     Abstract available


  42. CANDIA C, Fuschillo S, Ambrosino P, Motta A, et al
    Exercise-based pulmonary rehabilitation for individuals with chronic obstructive pulmonary disease: What is the potential role of biomarkers? A narrative review.
    Respir Med. 2025;247:108282.
    PubMed     Abstract available


  43. DU BERRY C, Simpson SJ, Spittle AJ, Holland AE, et al
    Exercise training to address lifelong consequences of preterm birth: a survey of perceived needs.
    Respir Med. 2025;247:108284.
    PubMed     Abstract available


  44. NIEDERMAIER T, Alter P, Jorres R, Vogelmeier C, et al
    Parametric estimation of age-, sex-, and spirometry grade-specific mortality in a cohort of COPD patients from Germany: Results from COSYCONET.
    Respir Med. 2025;247:108280.
    PubMed     Abstract available


  45. BECK DA SILVA ETGES AP, Marcolino MAZ, Bianchini L, Kawano-Dourado L, et al
    Economic analysis of high-flow nasal oxygen compared with noninvasive ventilation in patients with acute respiratory failure: results from the RENOVATE randomized clinical trial.
    Respir Med. 2025;247:108270.
    PubMed     Abstract available


  46. VILLAR-AGUILAR L, Casal-Guisande M, Fernandez-Villar A, Garcia-Rodriguez E, et al
    Characterisation of patients with Alpha-1 antitrypsin deficiency using unsupervised machine learning tools.
    Respir Med. 2025;247:108278.
    PubMed     Abstract available


  47. SHAHID H, Ahmed M, Sami SZ, Kumar S, et al
    High-intensity versus low-intensity non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2025;247:108277.
    PubMed     Abstract available


  48. VERMA B, Kumar N, Ashique S, Debnath B, et al
    Probiotics: An adjuvant treatment strategy for chronic respiratory diseases.
    Respir Med. 2025;247:108268.
    PubMed     Abstract available


  49. EGGLESTON RH, Torghabeh MH, Niven AS, Lim KG, et al
    Bronchodilator Response: Utility and implications in patients undergoing hematopoietic stem cell transplantation.
    Respir Med. 2025;247:108259.
    PubMed     Abstract available


  50. BUENDIA JA, Manrique Acevedo LF, Celis Preciado C
    "Beyond triple Therapy: Is dupilumab a cost-effective option for COPD with type 2 inflammation?".
    Respir Med. 2025;247:108254.
    PubMed     Abstract available


    September 2025
  51. BROZEK G, Nowak B, Prendergast C, Gil A, et al
    Thirty year trends in childhood asthma and allergic conditions in Poland.
    Respir Med. 2025;248:108379.
    PubMed     Abstract available


  52. ALAM ABMN, Gill N, AlAshoor M, Cherif I, et al
    SGLT2-inhibitors and asthma outcomes in type 2 diabetes: Insights from a large multicenter study.
    Respir Med. 2025;248:108357.
    PubMed     Abstract available


  53. FABOZZI A, Bouloukaki I, Bonini M, Schiza SE, et al
    Asthma-OSA overlap syndrome: A distinct endophenotype?
    Respir Med. 2025;248:108344.
    PubMed     Abstract available


  54. HARVEY ES, Hamada Y, Hiles SA, Langton D, et al
    Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry.
    Respir Med. 2025 Sep 3:108340. doi: 10.1016/j.rmed.2025.108340.
    PubMed     Abstract available


  55. DAL NEGRO RW, Turco P, Povero M
    Sensitivity and specificity of various lung function parameters recommended for phenotyping COPD in clinical practice.
    Respir Med. 2025;246:108256.
    PubMed     Abstract available


  56. FERRAZ BD, Faria N, Lacerda C, Mona D, et al
    Spirometry to predict dry powder inhaler performance: Insights from in-check DIAL.
    Respir Med. 2025;246:108249.
    PubMed     Abstract available


  57. BAJPAI J, Kant S, Matera MG, Cazzola M, et al
    Targeting neutrophilic inflammation in obstructive airway disease - A narrative review of brensocatib therapy.
    Respir Med. 2025;246:108243.
    PubMed     Abstract available


  58. WANG JG, Colangelo LA, Meislin R, Khan SS, et al
    Adverse pregnancy outcomes and lung function later in life: The CARDIA lung study.
    Respir Med. 2025;246:108244.
    PubMed     Abstract available


  59. BJORKLUND F, Palm A, Sundh J, Ekstrom M, et al
    A lung function threshold for survival? - FEV(1)Q and mortality in patients with COPD and chronic respiratory failure.
    Respir Med. 2025;246:108242.
    PubMed     Abstract available


  60. BAMONTI PM, Wingood M, Robinson SA, Rose GA, et al
    Psychometric evaluation of the exercise self-regulatory efficacy scale using objective measures of physical functioning in persons with chronic obstructive pulmonary disease.
    Respir Med. 2025;246:108228.
    PubMed     Abstract available


  61. MARQUES A, Antao J, Rodrigues G, Paixao C, et al
    Pulmonary rehabilitation in minimal versus high resource settings in COPD: a non-inferiority and economic evaluation.
    Respir Med. 2025;246:108229.
    PubMed     Abstract available


  62. LI Y, Li X, Li Z, Luo T, et al
    Visceral fat-to-muscle mass ratio to predict cardiovascular events and mortality in patients with chronic obstructive pulmonary disease: A prospective cohort study.
    Respir Med. 2025;246:108215.
    PubMed     Abstract available


  63. HOLM KE, Sandhaus RA, Allison S, Schroth T, et al
    Sleep apnea among individuals with Alpha-1 antitrypsin deficiency-associated lung disease.
    Respir Med. 2025;246:108217.
    PubMed     Abstract available


    August 2025
  64. CELEBI SOZENER Z, Ozdel Ozturk B, Sahinoglu E, Koyluce S, et al
    Benralizumab In Severe Eosinophilic Asthma: A Real-Life Data From Turkiye.
    Respir Med. 2025 Aug 28:108332. doi: 10.1016/j.rmed.2025.108332.
    PubMed     Abstract available


  65. OLIVEIRA JM, Urroz Guerrero PD, Lewthwaite H, Clark VL, et al
    Safety of the 6-minute walk test in adults with severe asthma.
    Respir Med. 2025 Aug 21:108316. doi: 10.1016/j.rmed.2025.108316.
    PubMed     Abstract available


  66. BRIDEVAUX PO, Bourdin A, VAN Ganse E
    Substantial Reduction in Oral Corticosteroid Use After Biologics Initiation in Severe Asthma: An Analysis Based on Swiss Pharmacy Data.
    Respir Med. 2025 Aug 21:108312. doi: 10.1016/j.rmed.2025.108312.
    PubMed     Abstract available


  67. GREIG R, Suter P, Chan R, Lipworth B, et al
    Impact of dupilumab on oscillometry and spirometry derived ratios in severe refractory asthma.
    Respir Med. 2025;247:108315.
    PubMed     Abstract available


  68. CHAN R, Cottini M, Menzella F, Poto R, et al
    Body mass index and lung function decline in persistent asthma.
    Respir Med. 2025 Aug 11:108304. doi: 10.1016/j.rmed.2025.108304.
    PubMed    


  69. HOGAARD NV, Sigsgaard T, Agertoft L, Halken S, et al
    Effect of indoor environmental interventions in the home on asthma in children and adolescents: A systematic review.
    Respir Med. 2025 Aug 5:108299. doi: 10.1016/j.rmed.2025.108299.
    PubMed     Abstract available


  70. PATEL C, Sheth V, Koppula R, Kumar A, et al
    Efficacy and safety of novel fixed dose combination of vilanterol, glycopyrronium, and fluticasone furoate dry powder inhaler: A phase 3, randomized, non-inferiority trial compared with fixed dose combination of indacaterol, glycopyrronium, and mometa
    Respir Med. 2025;247:108293.
    PubMed     Abstract available


  71. TU D, Ju S, Xue Y, Xie W, et al
    Association between asthma and advanced cardiovascular-kidney-metabolic syndrome in U.S. adults, a cross-sectional study from NHANES 2011-2023.
    Respir Med. 2025;247:108288.
    PubMed     Abstract available


  72. HSU CC, Tung PH, Lin TY, Huang SW, et al
    Effect of chronic kidney disease on survival in patients with chronic obstructive pulmonary disease.
    Respir Med. 2025;244:108181.
    PubMed     Abstract available


  73. ELLINGSEN J, Janson C, Broms K, Farkhooy A, et al
    Clinical phenotypes predict exacerbations of COPD: the TIE cohort study.
    Respir Med. 2025;244:108182.
    PubMed     Abstract available


  74. HOCHHAUSEN N, Moza A, Kroh A, Rossaint R, et al
    Chronic obstructive pulmonary disease is associated with a higher incidence of acute kidney injury in non-cardiac but not in cardiac surgery ICU-patients: a retrospective MIMIC-III database analysis.
    Respir Med. 2025;244:108160.
    PubMed     Abstract available


  75. QU M, Yang L, Liu K, Tang T, et al
    The effectiveness and feasibility of virtual pulmonary rehabilitation in patients with chronic respiratory diseases: A systematic review and meta-analysis.
    Respir Med. 2025;244:108159.
    PubMed     Abstract available


  76. FAHRENBERG C, Niedermaier T, Alter P, Jorres RA, et al
    Analysis of change in health-related quality of life in patients with COPD over 6 years, including information on dropouts: Results from the German COSYCONET cohort.
    Respir Med. 2025;244:108153.
    PubMed     Abstract available


  77. ZHU B, Xue F, Li M, Chen Y, et al
    Long-term benefits of pulmonary rehabilitation with respiratory muscle training in people with COPD: A retrospective cohort study.
    Respir Med. 2025;245:108214.
    PubMed     Abstract available


  78. GIRI M, Puri A, Chen Y, Liu Y, et al
    Association between Pan-immune-inflammation value and in-hospital mortality in critically ill patients with Chronic obstructive pulmonary disease: An observational study.
    Respir Med. 2025;245:108213.
    PubMed     Abstract available


  79. ZHANG Y, Chen H, Hu S, Chen C, et al
    Construction and validation of a nomogram prediction model for death risk in patients with chronic obstructive pulmonary disease complicated by hypercapnic respiratory failure in the intensive care unit.
    Respir Med. 2025;245:108188.
    PubMed     Abstract available


  80. COLEMAN KM, Varrias D, Wolf E, Schwartz J, et al
    Unrecognized actionable cardiac arrhythmias in patients with moderate to severe chronic obstructive pulmonary Disease: Can continuous monitoring unmask the culprit.
    Respir Med. 2025;245:108190.
    PubMed     Abstract available


  81. HU Y, Hu Y, Dong M, Zheng S, et al
    Integrating clinical phenotypes, impulse oscillometry and fractional exhaled nitric oxide: a robust machine learning model for early asthma prediction in preschool children.
    Respir Med. 2025 Aug 1:108290. doi: 10.1016/j.rmed.2025.108290.
    PubMed     Abstract available


    July 2025
  82. TIRELLI C, Parazzini EM, Sacchi L, Carone G, et al
    Forced Oscillatory Technique R5-19 values correlate with spirometry FEV1/FVC in severe eosinophilic asthma. An observational, prospective, cohort study.
    Respir Med. 2025 Jul 16:108260. doi: 10.1016/j.rmed.2025.108260.
    PubMed     Abstract available


  83. PARK HJ, Lee CH, Lee JK, Kim DK, et al
    Radiologic emphysema predicts accelerated lung function decline in patients with asthma.
    Respir Med. 2025;247:108261.
    PubMed     Abstract available


  84. TIAN C, Xiong S, Song X, Li S, et al
    Spirometry and impulse oscillometry in the diagnosis of cough variant asthma in children.
    Respir Med. 2025;246:108255.
    PubMed     Abstract available


  85. KOH MS, Xu X, Wei Lam SS, Wu JT, et al
    Public health insights of patients with asthma receiving primary, specialist or mixed care in Singapore using data from the SDG-CARE Asthma Registry.
    Respir Med. 2025 Jul 11:108252. doi: 10.1016/j.rmed.2025.108252.
    PubMed     Abstract available


  86. ACHTERBOSCH M, Hansen CME, Brand PLP, van Dijk L, et al
    Shared decision making and inhaled medication adherence in patients with COPD, asthma and cystic fibrosis: a systematic review.
    Respir Med. 2025 Jul 11:108251. doi: 10.1016/j.rmed.2025.108251.
    PubMed    


  87. KISIEL MA, Zhou X, Fundberg I, Barrling A, et al
    Mortality and its predictive factors in participants with asthma: a 26-year follow-up.
    Respir Med. 2025;246:108253.
    PubMed     Abstract available


  88. BRAIDO F, Beeh KM, Serrano CC, Dinh-Xuan AT, et al
    Real-world use of beclometasone dipropionate and formoterol fumarate NEXThaler(R) and asthma control among adult asthmatic patients in Europe: The results of the NEWTON Study.
    Respir Med. 2025 Jul 9:108224. doi: 10.1016/j.rmed.2025.108224.
    PubMed     Abstract available


  89. DIEZ SIERRA J, Medina Gallardo JF, Munoz Sanchez B, Leon Lloreda A, et al
    FEV(1) Decline and Clinical Predictors in Asthma after 10 Years of Follow-Up: BMI as a Modifiable Risk Factor.
    Respir Med. 2025 Jul 4:108247. doi: 10.1016/j.rmed.2025.108247.
    PubMed     Abstract available


  90. AKSAMIT TR, Choate R, Mannino DM, Brunton AE, et al
    Natural history and burden of refractory Mycobacterium avium complex pulmonary disease: insights from the US Bronchiectasis and Nontuberculous Mycobacterial Research Registry.
    Respir Med. 2025 Jul 2:108220. doi: 10.1016/j.rmed.2025.108220.
    PubMed     Abstract available


  91. SHINGAI K, Ikeuchi T, Rassam P, Kozu R, et al
    Development of a new ambulatory oxygen delivery method combining continuous oxygen flow and demand oxygen delivery system: A prospective, single-blind, randomized crossover trial.
    Respir Med. 2025;243:108140.
    PubMed     Abstract available


  92. MAHAJAN AK, Collar N, Muldowney F, Ochoa Cuba MA, et al
    Incidence and outcomes for post-bronchoscopic lung volume reduction (BLVR) pneumothoraces stratified by target lobe treated.
    Respir Med. 2025;243:108148.
    PubMed     Abstract available


  93. ANYETEI-ANUM GP, White B, Yadav H, Kennedy CC, et al
    Effect of native lung disease on post-transplant best lung function.
    Respir Med. 2025;243:108128.
    PubMed     Abstract available


  94. MEKONNEN TC, Melaku YA, Shi Z, Gill TK, et al
    Joint analysis of diet quality, inflammatory potential of diet and ultra-processed food exposure in relation to chronic respiratory diseases and lung cancer mortality.
    Respir Med. 2025;243:108138.
    PubMed     Abstract available


  95. ROMERO-LINARES A, Alvarez-Muro L, Hammadi A, Hoyas-Sanchez C, et al
    Short term exacerbation risk and exhaled nitric oxide in COPD.
    Respir Med. 2025;243:108134.
    PubMed     Abstract available


  96. LOUGHRAN KJ, Trewartha G, Martin D, Fernandes-James C, et al
    Persistent pain is associated with poorer balance and gait performance for people with Chronic Obstructive Pulmonary Disease.
    Respir Med. 2025;243:108133.
    PubMed     Abstract available


  97. KLAPS S, Langer D, Gosselink R, Dacha S, et al
    The value of extra-diaphragmatic inspiratory muscle surface electromyography during postural control tasks in patients with chronic obstructive pulmonary disease.
    Respir Med. 2025;243:108127.
    PubMed     Abstract available


  98. HANSEN H, Godtfredsen N, Ulrik CS, Hansen J, et al
    Physical activity levels in Danish adults with and without asthma - A national recurrent cross-sectional case-control study from 2010 to 2021.
    Respir Med. 2025 Jul 1:108240. doi: 10.1016/j.rmed.2025.108240.
    PubMed     Abstract available


    June 2025
  99. ZHU W, Chen K, Xiang Y, Shi J, et al
    Real-World Respiratory Effectiveness of mepolizumab in Severe Eosinophilic Asthma and Eosinophilic Granulomatosis with Polyangiitis.
    Respir Med. 2025 Jun 26:108223. doi: 10.1016/j.rmed.2025.108223.
    PubMed     Abstract available


  100. ANTAO J, Rodrigues G, Deng Q, Baak BN, et al
    Trends in initial pharmacological treatment of asthma in primary care (2010-2021): A population-based study using the PHARMO data network.
    Respir Med. 2025;246:108222.
    PubMed     Abstract available


  101. ZHENG X, Jiang H, Cui R, Cai A, et al
    From Itchy Skin to Wheezing: Potential biomarkers and targeted drugs for Atopic Dermatitis and Asthma in Children.
    Respir Med. 2025 Jun 13:108212. doi: 10.1016/j.rmed.2025.108212.
    PubMed     Abstract available


  102. FREUND O, Hadad Y, Bergeron A, Fried S, et al
    Bronchiectasis after allogeneic hematopoietic cell transplantation - an underdiagnosed complication.
    Respir Med. 2025;245:108208.
    PubMed     Abstract available


  103. HANSEN S, Hakansson KEJ, Soendergaard MB, Bjerrum AS, et al
    Clinical response and remission in patients treated with dupilumab for severe asthma: Results from the nationwide Danish Severe Asthma Register.
    Respir Med. 2025 Jun 11:108203. doi: 10.1016/j.rmed.2025.108203.
    PubMed     Abstract available


  104. PINI L, Caminati M, Maule M, Bagnasco D, et al
    ICS use trajectories in severe asthma patients on benralizumab: real-life data from 3-years follow-up.
    Respir Med. 2025;245:108198.
    PubMed     Abstract available


  105. BRAUNWALDER C, Ertl J, Wullschleger M, Timm E, et al
    Efficacy and safety of phytotherapy and anthroposophic medicine in bronchial asthma: A systematic review.
    Respir Med. 2025 Jun 7:108202. doi: 10.1016/j.rmed.2025.108202.
    PubMed     Abstract available


  106. TAY TR, Pang E, Liew MF, Tiew PY, et al
    Ethnic variation in South East Asian patients with Severe Asthma: A First Look at the Singapore Severe Asthma Registry (SSAR) and implications on clinical practice.
    Respir Med. 2025 Jun 5:108199. doi: 10.1016/j.rmed.2025.108199.
    PubMed     Abstract available


  107. COOPER DH, Akbarian N, Aaron SD, Luks V, et al
    Glucagon-like Peptide 1 (GLP-1) Receptor Agonists and Asthma and COPD Exacerbations in Adults with Diabetes: A Systematic Review.
    Respir Med. 2025 Jun 4:108197. doi: 10.1016/j.rmed.2025.108197.
    PubMed     Abstract available


  108. LI H, Huang X, Wei Z, Chen Z, et al
    Unveiling genetic links: GSDMB polymorphisms and asthma susceptibility in the Zhuang Nationality of Guangxi.
    Respir Med. 2025;245:108176.
    PubMed     Abstract available


  109. MATTA A, Polychronopoulou E, Kuo YF, Sharma G, et al
    Pulmonary rehabilitation utilization in patients with chronic respiratory diseases: 2014-2019.
    Respir Med. 2025;242:108110.
    PubMed     Abstract available


  110. LIGUORO I, Patui M, Vidoni M, Pilotto C, et al
    Comparison of the sensitivity and specificity of bronchiolitis severity scores in infants: a systematic review and meta-analysis.
    Respir Med. 2025;242:108111.
    PubMed     Abstract available


  111. BENFANTE A, Tomasello A, Pitruzzella A, Fucarino A, et al
    Exploring a novel approach to COPD treatment: benralizumab effect in an ex vivo 3-D model.
    Respir Med. 2025;242:108107.
    PubMed     Abstract available


  112. JALALVAND M, Tahermohammadi H, Madreseh E, Varahram M, et al
    Regulatory T cells in the blood of patients with chronic obstructive pulmonary disease (COPD): A systematic review and meta-analysis.
    Respir Med. 2025;242:108104.
    PubMed     Abstract available


  113. FANDOS VAZQUEZ P, Diez-Manglano J
    Thyroid hormones in people with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2025;242:108103.
    PubMed     Abstract available


  114. PIERRE C, Jeanne I, Mathieu B, Hugo G, et al
    Characteristics and risk factors of intubation in COPD patients with severe acute exacerbation: An exploratory single-center retrospective study.
    Respir Med. 2025;242:108095.
    PubMed     Abstract available


    May 2025
  115. HANANIA NA, Stanford R, Rendon A, Gemicioglu B, et al
    Comparative effectiveness of inhaled fluticasone propionate/salmeterol and budesonide/formoterol fixed-dose combinations in asthma control - a retrospective United States database analysis.
    Respir Med. 2025 May 28:108172. doi: 10.1016/j.rmed.2025.108172.
    PubMed     Abstract available


  116. ZHANG X, Zhang X, Wan Y, Xu D, et al
    The association between alpha-1-acid glycoprotein and asthma in United States: a cross-sectional study from NHANES.
    Respir Med. 2025;245:108174.
    PubMed     Abstract available


  117. ATALAY NA, Yormaz B, Sahin A, Sonmez G, et al
    Elevated HIF-1alpha as a Diagnostic Biomarker in COPD: Correlations with EPO, Emphysema Index, and Pulmonary Function.
    Respir Med. 2025 May 28:108184. doi: 10.1016/j.rmed.2025.108184.
    PubMed     Abstract available


  118. COTTINI M, Poto R, Bhattacharjee A, Galant S, et al
    Characterizing the preserved ratio impaired spirometry phenotype in all severities of asthma.
    Respir Med. 2025 May 27:108180. doi: 10.1016/j.rmed.2025.108180.
    PubMed     Abstract available


  119. DOUMAT G, Aksamit TR, Kanj AN
    Bronchiectasis: A clinical review of inflammation.
    Respir Med. 2025;244:108179.
    PubMed     Abstract available


  120. MOCHIZUKI F, Tanabe N, Iijima H, Shimada T, et al
    Prediction of airflow limitation in smokers using multiple CT imaging indices: airway wall thickness, quantitative emphysema, and visually identified centrilobular emphysema.
    Respir Med. 2025 May 20:108169. doi: 10.1016/j.rmed.2025.108169.
    PubMed     Abstract available


  121. XIANG J, Cui M
    Neutrophil Extracellular Traps and neutrophilic asthma.
    Respir Med. 2025 May 12:108150. doi: 10.1016/j.rmed.2025.108150.
    PubMed     Abstract available


  122. LEMACON C, Lopes AA
    Inhalers or nebulisation of salbutamol in childhood asthma exacerbations in emergency departments.
    Respir Med. 2025 May 8:108152. doi: 10.1016/j.rmed.2025.108152.
    PubMed     Abstract available


  123. MOERMANS C, Decerf N, Javaux N, Onssels A, et al
    High local type-2 inflammation is linked to response in severe asthma treated with anti-Interleukin-5 receptor.
    Respir Med. 2025 May 7:108151. doi: 10.1016/j.rmed.2025.108151.
    PubMed     Abstract available


  124. ZHONG Z, Zhang C, Zhao L, Zhao Y, et al
    Inhaled tobramycin in non-cystic fibrosis bronchiectasis: A meta-analysis of randomized controlled trials.
    Respir Med. 2025 May 6:108136. doi: 10.1016/j.rmed.2025.108136.
    PubMed     Abstract available


  125. WENNERGREN G, Lindberg A, Kauppi P, Kankaanranta H, et al
    Glimpses of diagnostic tools and treatment of asthma in Sweden, Norway, and Finland from a medico-historical perspective.
    Respir Med. 2025;243:108139.
    PubMed     Abstract available


  126. BULKHI AA, Elkkari A, Alghamdi BJ, Mahboub B, et al
    Defining Clinical Remission in Severe Asthma: Expert Opinion from the Gulf Region Using the Modified Delphi Method.
    Respir Med. 2025 May 3:108132. doi: 10.1016/j.rmed.2025.108132.
    PubMed     Abstract available


  127. OISHI K, Yasui H, Inoue Y, Hozumi H, et al
    The role of arterial stiffness as assessed by the cardio-ankle vascular index in patients with chronic obstructive pulmonary disease.
    Respir Med. 2025;241:108078.
    PubMed     Abstract available


  128. JIN C, Jin R, Liu D, Li Y, et al
    Genetically determined alpha-Klotho levels and causal association with aging-related lung diseases.
    Respir Med. 2025;241:108081.
    PubMed     Abstract available


  129. LU L, Wu F, Tang G, Wan Q, et al
    Associations of small airway dysfunction assessed by impulse oscillometry with lung function decline and exacerbations in participants with chronic obstructive pulmonary disease: A prospective cohort study in China.
    Respir Med. 2025;241:108075.
    PubMed     Abstract available


  130. ROBLES-HERNANDEZ RE, Montiel-Lopez F, Velazquez-Uncal M, Sansores RH, et al
    Efficacy of Indacaterol vs Tiotropium in COPD patients due to biomass exposure in improving quality of life and reducing symptoms.
    Respir Med. 2025;241:108074.
    PubMed     Abstract available


  131. ELIASON G, Ekstrom M, Montgomery S, Giezeman M, et al
    Associations of comorbid heart disease and depression/anxiety with multidimensional breathlessness in COPD - A cross-sectional study.
    Respir Med. 2025;241:108053.
    PubMed     Abstract available


  132. MALVI A, Khatib MN, Ganesan S, Kaur M, et al
    Assessing the impact of electronic nicotine delivery systems on chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2025;241:108059.
    PubMed     Abstract available


  133. PISTENMAA CL, Hoffman EA, Prince MR, Hughes E, et al
    Platelet activation and COPD-related clinical and imaging characteristics: The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study.
    Respir Med. 2025;241:108058.
    PubMed     Abstract available


  134. MENDES MA, Janssen DJ, Marques A
    Palliative care education as an integrated component of pulmonary rehabilitation: A real-world mixed-methods feasibility study.
    Respir Med. 2025;241:108034.
    PubMed     Abstract available


  135. RO S, Aso S, Matsui H, Fushimi K, et al
    Association of once-daily single-device dual bronchodilators with prevention of rehospitalization for chronic obstructive pulmonary disease: A retrospective national inpatient database study.
    Respir Med. 2025;241:108033.
    PubMed     Abstract available


  136. VOGELMEIER CF, Rabe KF, Bhatt SP, Hanania NA, et al
    Dupilumab reduces acute exacerbations and improves lung function in patients with COPD with type 2 inflammation irrespective of body mass index, airflow obstruction, dyspnea, and exercise capacity index scores.
    Respir Med. 2025;241:108015.
    PubMed     Abstract available


    April 2025
  137. TSE SM, Babatounde AK, Drouin O, Radhakrishnan D, et al
    The association between the stringency of COVID-19 public health mitigation strategies and pediatric asthma-related hospitalizations in Canada: an ecological study over 2 years.
    Respir Med. 2025;243:108125.
    PubMed     Abstract available


  138. HUETHER KM, Lamb JM, Skelly J, Brigham E, et al
    Omega-3 Fatty Acid Intake Potentiates Bronchodilator Response in Patients with Obesity and Poorly Controlled Asthma.
    Respir Med. 2025 Apr 26:108131. doi: 10.1016/j.rmed.2025.108131.
    PubMed     Abstract available


  139. GHERASIM A, Dietsch F, Odul F, Riff T, et al
    Efficacy of air cleaners to reduce allergic responses to cat: a randomized clinical trial using an environmental exposure chamber.
    Respir Med. 2025 Apr 15:108105. doi: 10.1016/j.rmed.2025.108105.
    PubMed     Abstract available


  140. UNSAL H, Karaguzel D, Sarac BE, Aytekin ES, et al
    Inflammatory and oxidative stress markers in serum, urine and exhaled breath condensate: Relationship between asthma and obesity in children.
    Respir Med. 2025;242:108096.
    PubMed     Abstract available


  141. ERTAN YAZAR E, Karadag EH, Eren FA, Demirci B, et al
    Validation of probable COPD as proposed by the Lancet Commission at a smoking cessation clinic.
    Respir Med. 2025;239:108004.
    PubMed     Abstract available


  142. CHEN Z, Yue H, Gu Y, Xie C, et al
    Effect of traditional Chinese exercise on pulmonary function in middle-aged and older patients with stable chronic obstructive pulmonary disease: A randomized controlled trial.
    Respir Med. 2025;239:107997.
    PubMed     Abstract available


  143. SUN F, Ye M, Jumahan A, Aainiwaier A, et al
    MHR as a promising predictor for coronary artery disease in COPD patients: Insights from a retrospective nomogram study.
    Respir Med. 2025;239:107993.
    PubMed     Abstract available


  144. WARDYN PM, de Broucker V, Perez T, Demoulin-Alexikova S, et al
    Comparison of GLI-2021 standards with ECSC standards for static lung volume interpretation in patients with respiratory diseases.
    Respir Med. 2025;239:107988.
    PubMed     Abstract available


  145. SONG C, Hao X, Critselis E, Panagiotakos D, et al
    The impact of electronic cigarette use on chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2025;239:107985.
    PubMed     Abstract available


  146. TAKIZAWA A, Shimada T, Chubachi S, Arai T, et al
    Exploring the pathophysiology of anemia in COPD: Insights from chest CT and longitudinal clinical data.
    Respir Med. 2025;240:108046.
    PubMed     Abstract available


  147. PIHLAJA H, Piili RP, Nuutinen M, Saarto T, et al
    The use of specialist palliative care services differs in chronic obstructive pulmonary disease and interstitial lung disease: A national cohort study.
    Respir Med. 2025;240:108045.
    PubMed     Abstract available


  148. DY ABC, Voraphani N, Spangenberg A, Belinsky SA, et al
    Circulating CC16, immune response to Mycoplasma pneumoniae and lung function: a population-based, multi-cohort study.
    Respir Med. 2025;240:108044.
    PubMed     Abstract available


  149. ZHANG S, Lin J
    Association of circadian syndrome and lung health: A population-based cohort study.
    Respir Med. 2025;240:108031.
    PubMed     Abstract available


  150. LIU Y, Huang J, Li E, Xiao Y, et al
    Analysis of research trends and hot spots on COPD biomarkers from the perspective of bibliometrics.
    Respir Med. 2025;240:108030.
    PubMed     Abstract available


  151. SATO H, Nagano T, Suraya R, Hazama D, et al
    Reduction in circulating Endothelin-1 levels by inhaled COPD medications.
    Respir Med. 2025;240:108027.
    PubMed     Abstract available


  152. SPITTLE DA, Pye A, Stanka J, De Soyza J, et al
    Bacterial colonisation doubles the risk of exacerbation in alpha-1 antitrypsin deficiency.
    Respir Med. 2025;240:108025.
    PubMed     Abstract available


  153. DAVOUDI DASTENAEI F, Belyani S, Esfahani AJ, Bahari H, et al
    Association of lifestyle components with prevalence of chronic obstructive pulmonary disease (COPD): Findings of a cohort study.
    Respir Med. 2025;240:108013.
    PubMed     Abstract available


  154. WEGLARZ K, Szczygiel E, Maslon A, Blaut J, et al
    Assessment of breathing patterns and voice of patients with COPD and dysphonia.
    Respir Med. 2025;240:108012.
    PubMed     Abstract available


  155. CANO A, Esteban C, Larrea N, Iriberri M, et al
    Factors associated with short- and medium-term mortality after hospitalization for COPD exacerbation.
    Respir Med. 2025;240:108010.
    PubMed     Abstract available


    March 2025
  156. STATEN T, Liu PH, Holt C, Alismail A, et al
    Effectiveness Of A Respiratory Therapist-Led, Community-Based Asthma Program In An Under resourced Rural Border Town In California.
    Respir Med. 2025 Mar 29:108071. doi: 10.1016/j.rmed.2025.108071.
    PubMed     Abstract available


  157. GREIG R, Chan R, Lipworth B
    Oscillometry and spirometry derived ratios to assess small airways dysfunction in severe asthma patients taking tezepelumab.
    Respir Med. 2025;241:108072.
    PubMed    


  158. MENZELLA F, Cottini M, Lombardi C, Senna G, et al
    A Real-world Study on Tezepelumab Effectiveness in Severe Asthma Focusing on Small Airway Dysfunction.
    Respir Med. 2025 Mar 25:108054. doi: 10.1016/j.rmed.2025.108054.
    PubMed     Abstract available


  159. ECK S, Baumgartel A, Hapfelmeier A, Linde K, et al
    Effectiveness of an online asthma education program in adults with asthma in general practice: Results from a cluster randomised controlled trial.
    Respir Med. 2025;240:108041.
    PubMed     Abstract available


  160. GUINOSSI RM, Bertagni Mingotti CF, Burch MO, Teixeira Soares LA, et al
    Residential greenness, respiratory symptoms and lung function in children, adolescents and adults with asthma: a cross-sectional study.
    Respir Med. 2025 Mar 11:108038. doi: 10.1016/j.rmed.2025.108038.
    PubMed     Abstract available


  161. PELGROM AT, de Jongh IFHC, van den Aardweg JG, van Veen IHPAA, et al
    Analysis of the breathing pattern in patients with asthma during physical exercise: a cross-sectional study.
    Respir Med. 2025 Mar 11:108037. doi: 10.1016/j.rmed.2025.108037.
    PubMed     Abstract available


  162. ORTIZ J, Staggers KA, Adrish M, Hanania NA, et al
    Asthma outcomes in a safety net hospital system: A comparative study to a national cohort.
    Respir Med. 2025;240:108032.
    PubMed     Abstract available


  163. ZHAO C, Wang L, Zhang L, Wang Q, et al
    Asthma Exacerbation Comorbidity Index (AECI): Predicting In-Hospital Adverse Outcomes.
    Respir Med. 2025 Mar 3:108024. doi: 10.1016/j.rmed.2025.108024.
    PubMed     Abstract available


  164. GAO Q, Zhu H
    Investigating the risk factors for the coexistence of insomnia and its exacerbation in AECOPD.
    Respir Med. 2025;238:107987.
    PubMed     Abstract available


  165. OTTESEN TG, Rovsing AH, Ulrik CS
    Local and systemic adverse effects of inhaled corticosteroids - Does ciclesonide differ from other inhaled corticosteroids?
    Respir Med. 2025;238:107962.
    PubMed     Abstract available


  166. CHOUDHARY OA, Dhawan J, Sohrabipour S, Semenchuk J, et al
    Assessment of online YouTube videos as a source of information and instruction for pulmonary rehabilitation.
    Respir Med. 2025;238:107968.
    PubMed     Abstract available


  167. SOHRABIPOUR S, Ibrahim A, Dhawan J, Choudhary OA, et al
    Evaluation of online videos and websites on inspiratory muscle training for individuals with chronic lung disease.
    Respir Med. 2025;238:107967.
    PubMed     Abstract available


  168. SHI W, Li T, Leng Y, Li Q, et al
    Global prevalence of fatigue in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2025;238:107969.
    PubMed     Abstract available


  169. CALZETTA L, Pistocchini E, Laitano R, Gholamalishahi S, et al
    Efficacy and safety of long-acting muscarinic antagonists in COPD: A meta-analysis and meta-regression with a focus on aging.
    Respir Med. 2025;238:107956.
    PubMed     Abstract available


    February 2025
  170. SUN C, Li N, Xiao X, Zhang Q, et al
    Association between lipid accumulation products and asthma among adults: Data from National Health and Nutrition Examination Survey (NHANES) 2003-2018.
    Respir Med. 2025;240:108017.
    PubMed     Abstract available


  171. TONE K
    Corrigendum to "Nodular-bronchiectatic pattern in pulmonary Nocardiosis: Immune status and treatment outcomes in a multicenter retrospective Study" [Respir. Med. 237 (2025) 107922].
    Respir Med. 2025 Feb 28:108009. doi: 10.1016/j.rmed.2025.108009.
    PubMed    


  172. PORTACCI A, Iorillo I, Quaranta VN, Amendolara M, et al
    Diaphragm function in patients with asthma and healthy controls: a cross-sectional study.
    Respir Med. 2025 Feb 18:108008. doi: 10.1016/j.rmed.2025.108008.
    PubMed     Abstract available


  173. JIANG P, Lu H, Jiang Y, Li F, et al
    Association between the triglyceride-glucose index and mortality in the asthma population.
    Respir Med. 2025 Feb 8:107989. doi: 10.1016/j.rmed.2025.107989.
    PubMed     Abstract available


  174. CHIU SL, Chiang TI, Chen CL
    Identification and validation of SPP1 as a potential biomarker for COPD through comprehensive bioinformatics analysis.
    Respir Med. 2025;237:107953.
    PubMed     Abstract available


  175. GARCIA-MOGUEL I, Martinez-Mesa A, Andujar-Espinosa R, Diaz-Campos R, et al
    The impact of blood eosinophil count and FeNO on benralizumab effectiveness in clinical practice: An ORBE II subanalysis.
    Respir Med. 2025;237:107940.
    PubMed     Abstract available


  176. WANG D, Hua L, Bai W, Guo M, et al
    Peripheral blood immune cell dynamics associate with growth of incidental indeterminate pulmonary nodules.
    Respir Med. 2025;237:107947.
    PubMed     Abstract available


  177. MENDES LPS, Parreira VF, Rocha BC, Spencer LM, et al
    Glittre-ADL tests in three laps as an alternative to the five laps test.
    Respir Med. 2025;237:107945.
    PubMed     Abstract available


  178. ELMIGER A, Marcin T, Bovet L, Brun P, et al
    Pulmonary rehabilitation and functional independence: Impact on survival in patients with fibrotic interstitial lung disease or chronic obstructive pulmonary disease.
    Respir Med. 2025;237:107933.
    PubMed     Abstract available


  179. YANG Z, Zheng Y, Zhao J, Zhong Y, et al
    Impact of IL13 genetic polymorphisms on COPD susceptibility in the Chinese Han population.
    Respir Med. 2025;237:107923.
    PubMed     Abstract available


    January 2025
  180. TIOTIU A, Migueres N, Gonzalez-Barcala FJ, Roux P, et al
    Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal polyps.
    Respir Med. 2025;238:107979.
    PubMed     Abstract available


  181. OKAY B, Hatipoglu HU, Okay ZU, Sahin K, et al
    COMPARING MESH AND COMPRESSOR NEBULIZERS IN PULMONARY FUNCTION TEST IN PEDIATRIC ASTHMA ATTACKS: A DOUBLE-BLIND RANDOMIZED COMPARATIVE CLINICAL TRIAL.
    Respir Med. 2025 Jan 28:107966. doi: 10.1016/j.rmed.2025.107966.
    PubMed     Abstract available


  182. CAZZOLA M, Calzetta L, Matera MG, Rogliani P, et al
    Challenges in treating patients with comorbid asthma and bronchiectasis.
    Respir Med. 2025 Jan 21:107957. doi: 10.1016/j.rmed.2025.107957.
    PubMed     Abstract available


  183. COSINI FF, Bagnasco D, Braido F, Canonica GW, et al
    Background therapy in severe asthma on monoclonal antibody treatment in real life.
    Respir Med. 2025;237:107944.
    PubMed     Abstract available


  184. HORVATH A, Farkas A, Reti I, Ilyes N, et al
    Particularities of deposition of two ICS-LABA fixed dose combination dry powder aerosol drugs in the airways of COPD patients.
    Respir Med. 2025;236:107916.
    PubMed     Abstract available


  185. XU H, Jiang X, Zeng Q, Li R, et al
    Application of e-Health tools in the assessment of inhalation therapy adherence in patients with chronic obstructive pulmonary disease: Scoping review coupled with bibliometric analysis.
    Respir Med. 2025;236:107898.
    PubMed     Abstract available


  186. KRIMSKY WS, VanderLaan PA, Iding JS, Hunter DW, et al
    A quantitative method for assessing treatment-related changes within the airway mucosa in patients with chronic bronchitis.
    Respir Med. 2025;236:107889.
    PubMed     Abstract available


  187. DELBRESSINE JM, Vaes AW, Stoop WAM, Van Ranst D, et al
    Reproducibility of three 6-min walk tests in patients with COPD referred for pulmonary rehabilitation.
    Respir Med. 2025;236:107884.
    PubMed     Abstract available


  188. YAPPALPARVI A, Balaraman AK, Padmapriya G, Gaidhane S, et al
    Safety and efficacy of ensifentrine in COPD: A systemic review and meta-analysis.
    Respir Med. 2025;236:107863.
    PubMed     Abstract available


    December 2024
  189. HASEGAWA A, Tone K, Baba Y, Saito Z, et al
    Nodular-bronchiectatic Pattern in Pulmonary Nocardiosis: Immune Status and Treatment Outcomes in a Multicenter Retrospective Study.
    Respir Med. 2024 Dec 23:107922. doi: 10.1016/j.rmed.2024.107922.
    PubMed     Abstract available


  190. BELHASSEN M, Marchal C, Deygas F, Jacoud F, et al
    In patients with asthma, obesity status is associated with poor control and high exacerbation rates, which are reversed after bariatric surgery.
    Respir Med. 2024;236:107917.
    PubMed     Abstract available


  191. AJAZ M, Singh I, Vugic L, Jani R, et al
    The interplay of plant-based antioxidants, inflammation, and clinical outcomes in asthma: A systematic review.
    Respir Med. 2024;236:107918.
    PubMed     Abstract available


  192. ALFAHL Z, Einarsson GG, Elborn JS, Gilpin DF, et al
    Airway total bacterial density, microbiota community composition and relationship with clinical parameters in bronchiectasis.
    Respir Med. 2024;236:107906.
    PubMed     Abstract available


  193. DONOHUE P, Connolly M, D'Alfonso M, Jackson G, et al
    Peripheral Airways Dysfunction Measured by Oscillometry Differentiates Asthma from Inducible Laryngeal Obstruction.
    Respir Med. 2024 Dec 2:107905. doi: 10.1016/j.rmed.2024.107905.
    PubMed     Abstract available


  194. PETAT H, Marguet C
    Three-year outcome of a very young severe uncontrolled preschool wheezers cohort, a real-life study.
    Respir Med. 2024;235:107875.
    PubMed     Abstract available


  195. SCIOSCIA G, Baraldi F, Bigoni T, Papi A, et al
    The precision medicine strategy to treat COPD pulmonary traits in clinical practice: The role of N-acetylcysteine.
    Respir Med. 2024;235:107865.
    PubMed     Abstract available


    November 2024
  196. GEMICIOGLU B, Gokmen D, Can A, Sevinc C, et al
    Factors Influencing the Prescription of Add-on Long-Acting Muscarinic Antagonists in Real-World Asthma Management: Insights from a National Registry.
    Respir Med. 2024 Nov 29:107883. doi: 10.1016/j.rmed.2024.107883.
    PubMed     Abstract available


  197. FARSHID S, Buckland BC, Shanmuganathan S, Low GK, et al
    End-tidal carbon dioxide, a point-of-care biomarker to assess severity in acute asthma: A systematic review.
    Respir Med. 2024 Nov 29:107891. doi: 10.1016/j.rmed.2024.107891.
    PubMed     Abstract available


  198. YASUI H, Oishi K, Nihashi F, Furuhashi K, et al
    Factors associated with uncontrolled severe asthma in the biologic era.
    Respir Med. 2024;236:107881.
    PubMed     Abstract available


  199. ERRASTI VIADER J, Martinez Gonzalez MA, Campo Ezquibela A, Bes-Rastrollo M, et al
    Dietary patterns and asthma incidence in adult population. Systematic review and meta-analysis.
    Respir Med. 2024 Nov 19:107861. doi: 10.1016/j.rmed.2024.107861.
    PubMed     Abstract available


  200. GANGEMI AJ, Dass CA, Zhao H, Patel M, et al
    Advanced Emphysema Leads to High False Positivity Rate for Pneumothorax in Point of Care Ultrasound.
    Respir Med. 2024 Nov 16:107860. doi: 10.1016/j.rmed.2024.107860.
    PubMed     Abstract available


  201. SESHADRI N, Faig W, Young LR, Hill DA, et al
    Risk Factors for Hospitalization in Subspecialty Patients with Severe Persistent Asthma.
    Respir Med. 2024 Nov 15:107867. doi: 10.1016/j.rmed.2024.107867.
    PubMed     Abstract available


  202. GOMEZ LF, Kinnee E, Kaufman JD, Young MT, et al
    Modification of asthma treatment efficacy by healthcare access: A reanalysis of AsthmaNet Step-Up Yellow Zone Inhaled Corticosteroids to Prevent Exacerbations (STICS) clinical trial.
    Respir Med. 2024;234:107853.
    PubMed     Abstract available


  203. HUG S, Cavalheri V, Hill K, Gucciardi DF, et al
    Road to referral success in COPD: Enhancing patient engagement through dedicated conversations about pulmonary rehabilitation programs.
    Respir Med. 2024;233:107790.
    PubMed     Abstract available


  204. LI C, Lian X, He J, Gao X, et al
    Association of computed tomography-derived pectoralis muscle area and density with disease severity and respiratory symptoms in patients with chronic obstructive pulmonary disease: A case-control study.
    Respir Med. 2024;233:107783.
    PubMed     Abstract available


  205. GRASL MT, Agusti A, Azizzadeh M, Karimi A, et al
    Prevalence and etiotypes of persistent airflow obstruction in the general population across the lifetime.
    Respir Med. 2024;233:107779.
    PubMed     Abstract available


  206. HAMADA R, Tanabe N, Oshima Y, Yoshioka Y, et al
    Phase angle measured by bioelectrical impedance analysis in patients with chronic obstructive pulmonary disease: Associations with physical inactivity and frailty.
    Respir Med. 2024;233:107778.
    PubMed     Abstract available


  207. HANSEN KK, Hilberg O, Lokke A
    High prevalence of undiagnosed and treatment-requiring obstructive sleep apnea and nocturnal desaturation in outpatients with severe chronic obstructive pulmonary disease.
    Respir Med. 2024;233:107771.
    PubMed    


  208. ALQAHTANI JS, Arowosegbe A, Aldhahir AM, Alghamdi SM, et al
    Prevalence and burden of loneliness in COPD: A systematic review and meta-analysis.
    Respir Med. 2024;233:107768.
    PubMed     Abstract available


  209. IGNACIO CARLOTTO C, Bernardes S, Zanella P, Silva FM, et al
    Dietary patterns and risk of Chronic Obstructive Pulmonary Disease (COPD) and clinical outcomes in diagnosed patients: A scoping review.
    Respir Med. 2024;233:107773.
    PubMed     Abstract available


  210. BAKKER JT, Hartman JE, Klooster K, Charbonnier JP, et al
    Endobronchial valve treatment improves chest-CT diaphragm configuration in COPD.
    Respir Med. 2024;234:107856.
    PubMed     Abstract available


  211. BOERSMA R, Bakker JT, de Vries M, Raveling T, et al
    Defining a phenotype of severe COPD patients who develop chronic hypercapnia.
    Respir Med. 2024;234:107850.
    PubMed     Abstract available


  212. BUCHARDT STE, Weinreich UM, Lindgren FL, Lauridsen MD, et al
    Patient characteristics and mortality across diagnostic settings in COPD.
    Respir Med. 2024;234:107843.
    PubMed     Abstract available


  213. SAADI R, Rangwala R, Shaikh H, Laghi F, et al
    The effects of noninvasive respiratory support on swallowing physiology, airway protection, and respiratory-swallow pattern in adults: A systematic review.
    Respir Med. 2024;234:107844.
    PubMed     Abstract available


  214. PHANTAYUTH D, Chuaychoo B, Supaporn S, Nana A, et al
    Effectiveness of a 12-week combining tai chi and yoga program on pulmonary function and functional fitness in COPD patients.
    Respir Med. 2024;234:107842.
    PubMed     Abstract available


  215. HOU XF, Hou CG
    Association between acute tobacco exposure and fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease: National health and Nutrition Examination Survey (NHANES) 2007-2012.
    Respir Med. 2024;234:107831.
    PubMed     Abstract available


  216. CHOATE R, Holm KE, Sandhaus RA, Mannino DM, et al
    Physical and mental health trajectories: A longitudinal SF-36 analysis in Alpha-1 antitrypsin deficiency-associated COPD.
    Respir Med. 2024;234:107838.
    PubMed     Abstract available


  217. TOFOLI TM, Santin L, Medeiros L, Silva H, et al
    Determinant factors of sedentary time in individuals with COPD.
    Respir Med. 2024;234:107839.
    PubMed     Abstract available


  218. TAN DJ, Finlay P, Siu H, Fan IM, et al
    Impaired diffusing capacity and COPD incidence in adults with symptoms and normal spirometry.
    Respir Med. 2024;234:107832.
    PubMed     Abstract available


  219. COX NS, Barton C, Bondarenko J, Clark R, et al
    Characterizing pulmonary rehabilitation referrals from primary care.
    Respir Med. 2024;234:107822.
    PubMed     Abstract available


  220. SHANMUGAVEL GEETHA H, Teo YX, Ravichandran S, Perkit NR, et al
    Use of Sodium-glucose cotransporter 2 (SGLT 2) inhibitor is associated with reduced emergency room visits and hospitalizations in patients with Chronic obstructive pulmonary disease (COPD) and type 2 Diabetes Mellitus.
    Respir Med. 2024;234:107819.
    PubMed     Abstract available


  221. ZHU Z
    Advancements in automated classification of chronic obstructive pulmonary disease based on computed tomography imaging features through deep learning approaches.
    Respir Med. 2024;234:107809.
    PubMed     Abstract available


  222. SHI Q, Xu J, Zeng L, Lu Z, et al
    A nomogram for predicting short-term mortality in ICU patients with coexisting chronic obstructive pulmonary disease and congestive heart failure.
    Respir Med. 2024;234:107803.
    PubMed     Abstract available


  223. JANG JG, Kim Y, Shin SH, Min KH, et al
    The role of FEV(1)/FVC in the prediction of acute exacerbation of COPD.
    Respir Med. 2024;234:107780.
    PubMed     Abstract available


    October 2024
  224. BHATT SP, Rabe KF, Hanania NA, Vogelmeier CF, et al
    Dupilumab reduces exacerbations and improves lung function in patients with chronic obstructive pulmonary disease and emphysema: Phase 3 randomized trial (BOREAS).
    Respir Med. 2024 Oct 29:107846. doi: 10.1016/j.rmed.2024.107846.
    PubMed     Abstract available


  225. CAZZOLA M, Ora J, Calzetta L, Rogliani P, et al
    beta-Blockers and Asthma: Surprising Findings from the FAERS Database.
    Respir Med. 2024 Oct 26:107849. doi: 10.1016/j.rmed.2024.107849.
    PubMed     Abstract available


  226. BOURBEAU J
    In COPD- right treatment, right patient, right time, right approach?
    Respir Med. 2024;232:107769.
    PubMed    


  227. PANTAZOPOULOS I, Boutlas S, Mavrovounis G, Papalampidou A, et al
    Nasal high flow or noninvasive ventilation? navigating hypercapnic COPD exacerbation treatment: A randomized noninferiority clinical trial.
    Respir Med. 2024;232:107762.
    PubMed     Abstract available


  228. LAURIDSEN MD, Grontved S, Fosbol E, Johnsen SP, et al
    Treatment intensity level as a proxy for severity of chronic obstructive pulmonary disease: A risk stratification tool.
    Respir Med. 2024;232:107742.
    PubMed     Abstract available


  229. ZHENG K, Tang L, Wang X, Chen L, et al
    The risk factors for chronic cough in children: A meta-analysis covering five continents.
    Respir Med. 2024;232:107752.
    PubMed     Abstract available


  230. WU W, Guan L, Guo B, Yang Y, et al
    Respiratory physiological mechanism of two types of equal-intensity inspiratory muscle training in stable patients with chronic obstructive pulmonary disease.
    Respir Med. 2024;232:107747.
    PubMed     Abstract available


  231. WU WW
    Association of naples prognostic score and lung health: A population-based study.
    Respir Med. 2024;232:107751.
    PubMed     Abstract available


  232. DELACOSTE FBC, Goulart CDL, Guidoti AB, Turck P, et al
    Evaluating the impact of short-term nitrate-rich dietary supplementation on endothelial function in COPD: A randomized crossover study.
    Respir Med. 2024;232:107745.
    PubMed     Abstract available


  233. MUNOZ MONTIEL A, Ruiz-Esteban P, Domenech Del Rio A, Valdivielso P, et al
    The effect of pulmonary rehabilitation on cardiovascular risk, oxidative stress and systemic inflammation in patients with COPD.
    Respir Med. 2024;232:107740.
    PubMed     Abstract available


    September 2024
  234. HAMELMANN E, Csonka P, Roberts G, Vogelberg C, et al
    High burden of respiratory allergy in children warrants early identification and treatment with allergen immunotherapy.
    Respir Med. 2024 Sep 24:107812. doi: 10.1016/j.rmed.2024.107812.
    PubMed     Abstract available


  235. HAKANSSON KEJ, Alabdulkarim N, Guerrero SC, Backer V, et al
    Real-world phenotyping and risk assessment of childhood asthma burden using national registries.
    Respir Med. 2024;234:107808.
    PubMed     Abstract available


  236. NOPSOPON T, Brown A, Hahn G, Rank M, et al
    Temporal variation in the effectiveness of biologics in asthma: Effect modification by changing patient characteristics.
    Respir Med. 2024 Sep 9:107802. doi: 10.1016/j.rmed.2024.107802.
    PubMed     Abstract available


  237. FAT M, Andersen T, Fazio JC, Park SC, et al
    Association of bronchial disease on CT imaging and clinical definitions of chronic bronchitis in a single-center COPD phenotyping study.
    Respir Med. 2024;231:107733.
    PubMed     Abstract available


  238. BISHOP JA, Spencer LM, Dwyer TJ, McKeough ZJ, et al
    Patterns of physical activity of people with COPD during participation in a pulmonary rehabilitation program.
    Respir Med. 2024;231:107724.
    PubMed     Abstract available


  239. SCHAFAUSER NS, Sampaio LMM, Heubel AD, Kabbach EZ, et al
    Influence of heart failure (HF) comorbidity in chronic obstructive pulmonary disease (COPD) and isolated forms of HF and COPD on cardiovascular function during hospitalization.
    Respir Med. 2024;231:107731.
    PubMed     Abstract available


  240. WSHAH A, Alqatarneh N, Al-Nassan S, Goldstein R, et al
    Factors related to the implementation of pulmonary rehabilitation in Jordan: Perspective of healthcare professionals.
    Respir Med. 2024;231:107728.
    PubMed     Abstract available


  241. GUO L, Bilimoria SN, Kikuchi R, Hao A, et al
    Prevalence, incidence, and risk of chronic obstructive pulmonary disease among psoriasis patients.
    Respir Med. 2024;231:107729.
    PubMed     Abstract available


  242. SMIRNOVA N, Cross SH, Light A, Kavalieratos D, et al
    Racial differences in palliative care and hospice among adults with chronic obstructive pulmonary disease.
    Respir Med. 2024;231:107719.
    PubMed    


  243. QUEZADA WA, Angulo D, Murray S, Joo M, et al
    Exacerbation-like events in the 12 months prior to identification of chronic respiratory conditions in a primary care population.
    Respir Med. 2024;231:107695.
    PubMed     Abstract available


  244. RISEBROUGH NA, Mursleen S, Ndirangu K, Shah D, et al
    The long-term clinical and economic benefits of treating advanced COPD patients with single-inhaler triple therapy in Quebec, Canada - The IMPACT trial.
    Respir Med. 2024;231:107694.
    PubMed     Abstract available


    August 2024
  245. WHARTON R, Mathis N, Wang JG, Meislin R, et al
    Feasibility of Remote Spirometry Monitoring of Asthma in Pregnancy.
    Respir Med. 2024 Aug 24:107782. doi: 10.1016/j.rmed.2024.107782.
    PubMed    


  246. WEBB EM, Holland AE, Chang AB, Burr L, et al
    Current physiotherapy practice for adults with bronchiectasis: Data from the Australian bronchiectasis registry.
    Respir Med. 2024;233:107777.
    PubMed     Abstract available


  247. TERL M, Diamant Z, Kosturiak R, Jesenak M, et al
    Choosing the right biologic treatment for individual patients with severe asthma - lessons learnt from Picasso.
    Respir Med. 2024 Aug 22:107766. doi: 10.1016/j.rmed.2024.107766.
    PubMed     Abstract available


  248. NORWEG A, Oh C, Nolan A
    Onion Consumption is Protective Against Asthma Risk in Children: ROAD to Health Population-based Cohort Study.
    Respir Med. 2024 Aug 11:107767. doi: 10.1016/j.rmed.2024.107767.
    PubMed    


  249. DITTRICH AS, Kontogianni K, Unterschemmann AS, De Rossi S, et al
    Efficacy and safety of simultaneous combined Zephyr and Spiration valve therapy in patients with advanced pulmonary emphysema.
    Respir Med. 2024 Aug 2:107760. doi: 10.1016/j.rmed.2024.107760.
    PubMed     Abstract available


  250. KIZMAZ E, Telli Atalay O, Cetin N, Ugurlu E, et al
    Virtual reality for COPD exacerbation: A randomized controlled trial.
    Respir Med. 2024;230:107696.
    PubMed     Abstract available


  251. KARJALAINEN J, Vartiainen V, Tikkakoski A, Malmberg LP, et al
    Salbutamol Easyhaler provides non-inferior relief of methacholine induced bronchoconstriction in comparison to Ventoline Evohaler with spacer: A randomized trial.
    Respir Med. 2024;230:107693.
    PubMed     Abstract available


  252. NGUYEN KT, Brooks D, Macedo LG, Ellerton C, et al
    Balance measures for fall risk screening in community-dwelling older adults with COPD: A longitudinal analysis.
    Respir Med. 2024;230:107681.
    PubMed     Abstract available


  253. JOO H, Yoon HK, Hwang YI, Kim SH, et al
    Application of the Lancet Commission COPD classification to COPD Cohort Population in South Korea.
    Respir Med. 2024;230:107679.
    PubMed     Abstract available


    July 2024
  254. BULT L, Thelen JC, Rauh SP, Veen JCCMI', et al
    Dupilumab responder types and predicting factors in patients with type 2 severe asthma: a real-world cohort study.
    Respir Med. 2024 Jul 9:107720. doi: 10.1016/j.rmed.2024.107720.
    PubMed     Abstract available


  255. LOCCI C, Puci MV, Saderi L, Sotgiu G, et al
    The complex link between sleep-disordered breathing and asthma control in pediatric patients: a cross-sectional study.
    Respir Med. 2024 Jul 2:107730. doi: 10.1016/j.rmed.2024.107730.
    PubMed     Abstract available


  256. SORIANO JB, Polverino F
    Sexual activity and respiratory disease: A systematic review.
    Respir Med. 2024;228:107665.
    PubMed     Abstract available


  257. LIAO KM, Chiu CC, Lu HY
    The risk of secondary spontaneous pneumothorax in patients with chronic obstructive pulmonary disease in Taiwan.
    Respir Med. 2024;228:107672.
    PubMed     Abstract available


  258. LI L, Wang L, Zhang L, Zhao C, et al
    Frailty and in-hospital mortality in older patients with acute exacerbation of COPD: A real-world prospective cohort study.
    Respir Med. 2024;228:107663.
    PubMed     Abstract available


  259. YOUNES A, Mandigout S, Robin L, Borel B, et al
    What kind of non-pharmacological strategy for reducing sedentary behavior in COPD? Data from a scoping review.
    Respir Med. 2024;228:107662.
    PubMed     Abstract available


    June 2024
  260. VISSER CD, Faay MRA, Ozdemir A, Guchelaar HJ, et al
    Short-acting beta(2)-agonists (SABA) overuse in asthma and patients' perceptions for this behavior.
    Respir Med. 2024 Jun 25:107723. doi: 10.1016/j.rmed.2024.107723.
    PubMed     Abstract available


  261. PACKHAM S, Odling M, Bossios A, Konradsen JR, et al
    Adherence to inhaled corticosteroid therapy and treatment escalation in the Swedish adult asthma population.
    Respir Med. 2024;231:107714.
    PubMed     Abstract available


  262. HE ZF, Lin SZ, Pan CX, Chen ZM, et al
    The roles of bacteria and viruses in COPD-Bronchiectasis association: A prospective cohort study.
    Respir Med. 2024 Jun 7:107692. doi: 10.1016/j.rmed.2024.107692.
    PubMed     Abstract available


  263. MARTINEZ-GONZALEZ CL, Camargo Fajardo MCC, Martinez-Ortiz EJ, Segura Medina P, et al
    A soft systems approach of asthma management in children based on therapeutic education and e-learning.
    Respir Med. 2024 Jun 4:107691. doi: 10.1016/j.rmed.2024.107691.
    PubMed     Abstract available


  264. ISLAM N, Reid D
    Inhaled antibiotics: A promising drug delivery strategies for efficient treatment of lower respiratory tract infections (LRTIs) associated with antibiotic resistant biofilm-dwelling and intracellular bacterial pathogens.
    Respir Med. 2024;227:107661.
    PubMed     Abstract available


  265. RAZJOUYAN J, Hanania NA, Nowakowski S, Agrawal R, et al
    Identification of sleep phenotypes in COPD using machine learning-based cluster analysis.
    Respir Med. 2024;227:107641.
    PubMed     Abstract available


  266. CHOUDHURY P, Dasgupta S, Kar A, Sarkar S, et al
    Bioinformatics analysis of hypoxia associated genes and inflammatory cytokine profiling in COPD-PH.
    Respir Med. 2024;227:107658.
    PubMed     Abstract available


  267. KOSTER TD, Shah PL, Valipour A, Criner GJ, et al
    Optimizing clinical outcomes for bronchoscopic lung volume reduction with Zephyr(R) valves.
    Respir Med. 2024;227:107639.
    PubMed     Abstract available


  268. GOMES VMR, Pires MC, Delfino Pereira P, Schwarzbold AV, et al
    AB(2)CO risk score for in-hospital mortality of COVID-19 patients admitted to intensive care units.
    Respir Med. 2024;227:107635.
    PubMed     Abstract available


  269. ZELL-BARAN LM, Krefft SD, Strand M, Rose CS, et al
    Longitudinal changes in lung function following post-9/11 military deployment in symptomatic veterans.
    Respir Med. 2024;227:107638.
    PubMed     Abstract available


  270. YOHANNES AM, Casaburi R, Dryden S, Hanania NA, et al
    Sex differences and determinants of anxiety symptoms in patients with COPD initiating pulmonary rehabilitation.
    Respir Med. 2024;227:107633.
    PubMed     Abstract available


  271. LAPI F, Marconi E, Lombardo FP, Cricelli I, et al
    Development and validation of a prediction score to assess the risk of incurring in COPD-related exacerbations: a population-based study in primary care.
    Respir Med. 2024;227:107634.
    PubMed     Abstract available


    May 2024
  272. LO CASTO M, Marino S, Zammuto MM, Tomasello A, et al
    Patients with bronchiectasis have a lower combined risk of cardiovascular risk factors and cardiovascular comorbidity compared to patients with COPD.
    Respir Med. 2024;229:107683.
    PubMed     Abstract available


  273. AL-AHMAD M, Al Zaabi A, Madkour A, Alqaraghuli HA, et al
    Expert Consensus on Oral Corticosteroids Stewardship for the Treatment of Severe Asthma in the Middle East and Africa.
    Respir Med. 2024 May 21:107674. doi: 10.1016/j.rmed.2024.107674.
    PubMed     Abstract available


  274. AKSAMIT TR, Lapinel NC, Choate R, Feliciano J, et al
    Association between bronchiectasis exacerbations and longitudinal changes in FEV(1) in patients from the US Bronchiectasis and NTM Research Registry.
    Respir Med. 2024 May 9:107660. doi: 10.1016/j.rmed.2024.107660.
    PubMed     Abstract available


  275. ZHOU Y, Duan S, Zhang L, Peng F, et al
    Cost-effectiveness analysis of fluticasone furoate/umeclidinium bromide/vilanterol and umeclidinium bromide/vilanterol in the management of moderate and severe COPD in China.
    Respir Med. 2024;226:107632.
    PubMed     Abstract available


  276. BETANCOR D, Barroso B, Valverde-Monge M, Gomez-Lopez A, et al
    The discrepancy in bronchodilator response between ATS/ERS 2021 and 1991 criteria.
    Respir Med. 2024;226:107609.
    PubMed    


  277. STOUSTRUP AL, Janssen DJA, Nakken N, Wouters EFM, et al
    Association of inadequate social support and clinical outcomes in patients with chronic obstructive pulmonary disease - A cross-sectional study.
    Respir Med. 2024;226:107625.
    PubMed     Abstract available


  278. LUNDELL S, Isaksson U, Coe AB, Harrison SL, et al
    Swedish translation and psychometric testing of the Self-Conscious Emotions in COPD Questionnaire.
    Respir Med. 2024;226:107624.
    PubMed     Abstract available


  279. LUU B, Chinnadurai A, Choudhary O, Breede N, et al
    A comprehensive evaluation of online inhaler use techniques for obstructive airway disease.
    Respir Med. 2024;226:107607.
    PubMed     Abstract available


  280. ZYSMAN M, Coquelin A, Le Guen N, Solomiac A, et al
    Prevalence and disparities in influenza vaccination among patients with COPD: A French nationwide population study.
    Respir Med. 2024;226:107606.
    PubMed     Abstract available


    April 2024
  281. GOTO T, Hernandez CG, Tsujimoto Y, Kitagawa T, et al
    Are biologics effective on lung hyperinflation in patients with resistant asthma?
    Respir Med. 2024 Apr 30:107652. doi: 10.1016/j.rmed.2024.107652.
    PubMed    


  282. CAZZOLA M, Maniscalco M
    Are biologics effective on lung hyperinflation in patients with resistant asthma? A reply.
    Respir Med. 2024 Apr 26:107653. doi: 10.1016/j.rmed.2024.107653.
    PubMed    


  283. JI H, Tan LD, Hafzella G, Nguyen N, et al
    Navigating Biologic Therapies in Elderly Asthma.
    Respir Med. 2024 Apr 26:107655. doi: 10.1016/j.rmed.2024.107655.
    PubMed     Abstract available


  284. CANONICA GW, Domingo C, Lavoie KL, Kaliasethi A, et al
    Asthma patients' and physicians' perspectives on the burden and management of asthma: post-hoc analysis of APPaRENT 1 and 2 to assess predictors of treatment adherence.
    Respir Med. 2024 Apr 16:107637. doi: 10.1016/j.rmed.2024.107637.
    PubMed     Abstract available


  285. ROBERTS MH, Duh MS, Rothnie KJ, Zhang S, et al
    Development and validation of a claims-based algorithm to identify moderate exacerbations in patients with asthma treated in the US.
    Respir Med. 2024 Apr 7:107630. doi: 10.1016/j.rmed.2024.107630.
    PubMed     Abstract available


  286. SHENG DUH M, Roberts MH, Rothnie KJ, Cheng WY, et al
    Frequency and economic burden of exacerbations in inhaled corticosteroid/long-acting beta-agonist-treated patients with asthma: a retrospective US claims study.
    Respir Med. 2024 Apr 7:107629. doi: 10.1016/j.rmed.2024.107629.
    PubMed     Abstract available


  287. FARKAS A, Horvath A, Reti I, Ilyes N, et al
    Comparative study of the inhalation parameters of COPD patients through NEXThaler(R) and Ellipta(R) dry powder inhalers.
    Respir Med. 2024;224:107576.
    PubMed     Abstract available


  288. MONDAL P, Lopez SP, Khokhar A, Snyder D, et al
    The influence of body mass index on airway resistance in children with sickle cell disease: A longitudinal study based on impulse oscillometry.
    Respir Med. 2024;224:107564.
    PubMed     Abstract available


  289. MAROTT JL, Ingebrigtsen TS, Colak Y, Vestbo J, et al
    Predicting exacerbations in COPD in the Danish general population.
    Respir Med. 2024;224:107557.
    PubMed     Abstract available


  290. BROCKWAY K, Ahmed S
    Beyond breathing: Systematic review of global chronic obstructive pulmonary disease guidelines for pain management.
    Respir Med. 2024;224:107553.
    PubMed     Abstract available


  291. LAI K, Sun D, Dai R, Samoro R, et al
    Benralizumab efficacy and safety in severe asthma: A randomized trial in Asia.
    Respir Med. 2024 Apr 1:107611. doi: 10.1016/j.rmed.2024.107611.
    PubMed     Abstract available


  292. GOTO T, Banno M, Kimura R
    Revisiting the use of high flow nasal cannula in acute exacerbation of COPD and conclusion of trial.
    Respir Med. 2024;225:107602.
    PubMed    


  293. LORENZANA I, Galera R, Casitas R, Martinez-Ceron E, et al
    Dynamic hyperinflation is a risk factor for mortality and severe exacerbations in COPD patients.
    Respir Med. 2024;225:107597.
    PubMed     Abstract available


  294. XU X, Yin J, Yang Y, Liu H, et al
    Advances in co-pathogenesis of the united airway diseases.
    Respir Med. 2024;225:107580.
    PubMed     Abstract available


  295. STEGER M, Canuet M, Enache I, Goetsch T, et al
    Survival and response to pulmonary vasodilator therapies in patients with chronic obstructive pulmonary disease and pulmonary vascular phenotype.
    Respir Med. 2024;225:107585.
    PubMed     Abstract available


  296. BELL K, Lawson J, Penz E, Cammer A, et al
    Systematic review of tailored dietary advice and dietitian involvement in the treatment of chronic obstructive pulmonary disease (COPD).
    Respir Med. 2024;225:107584.
    PubMed     Abstract available


  297. VERWEEL L, Packham T, Goldstein R, Brooks D, et al
    Implementation of virtual pulmonary rehabilitation during the COVID-19 pandemic: Experiences and perceptions of patients and healthcare providers.
    Respir Med. 2024;225:107588.
    PubMed     Abstract available


  298. LUO L, Tang J, Du X, Li N, et al
    Chronic obstructive pulmonary disease and the airway microbiome: A review for clinicians.
    Respir Med. 2024;225:107586.
    PubMed     Abstract available


    March 2024
  299. YORGANCIOGLU A, Cruz AA, Garcia G, Lavoie KL, et al
    A network meta-analysis of the association between patient traits and response to regular dosing with ICS plus short-acting beta(2)-agonist reliever or ICS/formoterol reliever only in mild asthma.
    Respir Med. 2024 Mar 30:107610. doi: 10.1016/j.rmed.2024.107610.
    PubMed     Abstract available


  300. JEONG J, Nam YH, Sim DW, Kim BK, et al
    Relationship of computed tomography-based measurements with symptom perception and quality of life in patients with severe asthma.
    Respir Med. 2024;225:107598.
    PubMed     Abstract available


  301. WIJSMAN PC, Goorsenberg AWM, d'Hooghe JNS, Weersink EJM, et al
    Exhaled breath analyses for bronchial thermoplasty in severe asthma patients.
    Respir Med. 2024 Mar 4:107583. doi: 10.1016/j.rmed.2024.107583.
    PubMed     Abstract available


  302. NIERI D, Morani C, De Francesco M, Gaeta R, et al
    Enhanced prothrombotic and proinflammatory activity of circulating extracellular vesicles in acute exacerbations of chronic obstructive pulmonary disease.
    Respir Med. 2024;223:107563.
    PubMed     Abstract available


  303. LAI Y, Cavalheri V, Sawyer A, Hill K, et al
    Exercise training initiated early during hospitalisation in individuals with chronic obstructive pulmonary disease is safe and improves exercise capacity and physical function at hospital discharge: A systematic review and meta-analysis.
    Respir Med. 2024;223:107554.
    PubMed     Abstract available


  304. LAU F, Schupp T, Schmitt A, Reinhardt M, et al
    Prognostic impact of chronic obstructive pulmonary disease in patients with heart failure with mildly reduced ejection fraction.
    Respir Med. 2024;223:107536.
    PubMed     Abstract available


    February 2024
  305. MANISCALCO M, Candia C, Calabrese C, D'Amato M, et al
    Impact of biologics on lung hyperinflation in patients with severe asthma.
    Respir Med. 2024 Feb 29:107578. doi: 10.1016/j.rmed.2024.107578.
    PubMed     Abstract available


  306. ALMQVIST L, Andersson M, Backman H, Ronmark E, et al
    No remission in 60% of those with childhood-onset asthma - A population-based cohort followed from 8 to 28 years of age.
    Respir Med. 2024 Feb 26:107581. doi: 10.1016/j.rmed.2024.107581.
    PubMed     Abstract available


    November 2023
  307. LAVORINI F, Usmani OS, Salvi S, Rote K, et al
    A narrative review on the Synchrobreathe: A novel breath-actuated pressurised metered-dose inhaler for the treatment of obstructive airway diseases.
    Respir Med. 2023;219:107435.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.